Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Treasury Shares (2020 - 2025)

Tandem Diabetes Care's Treasury Shares history spans 6 years, with the latest figure at $297456.0 for Q4 2025.

  • For Q4 2025, Treasury Shares fell 92.04% year-over-year to $297456.0; the TTM value through Dec 2025 reached $297456.0, down 92.04%, while the annual FY2025 figure was $297456.0, 92.04% down from the prior year.
  • Treasury Shares reached $297456.0 in Q4 2025 per TNDM's latest filing, down from $3.7 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $3.7 million in Q4 2024 to a low of $297456.0 in Q4 2025.
  • Average Treasury Shares over 5 years is $1.9 million, with a median of $1.8 million recorded in 2022.
  • Peak YoY movement for Treasury Shares: surged 359.88% in 2021, then tumbled 92.04% in 2025.
  • A 5-year view of Treasury Shares shows it stood at $610731.0 in 2021, then skyrocketed by 200.27% to $1.8 million in 2022, then skyrocketed by 73.2% to $3.2 million in 2023, then grew by 17.71% to $3.7 million in 2024, then crashed by 92.04% to $297456.0 in 2025.
  • Per Business Quant, the three most recent readings for TNDM's Treasury Shares are $297456.0 (Q4 2025), $3.7 million (Q4 2024), and $3.2 million (Q4 2023).